Bank of New York Mellon
PLRX icon

Bank of New York Mellon’s Pliant Therapeutics PLRX Stock Holding History

Bank of New York Mellon’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3K Buy
16,032
+208
+1% +$253 ﹤0.01% 4268
2026
Q1 		$19.9K Hold
15,824
– – ﹤0.01% 4177
2025
Q4 		$19.3K Sell
15,824
-109
-0.7% -$164 ﹤0.01% 4167
2025
Q3 		$23.6K Sell
15,933
-102
-0.6% -$156 ﹤0.01% 4158
2025
Q2 		$18.6K Sell
16,035
-156,990
-91% -$222K ﹤0.01% 4116
2025
Q1 		$234K Sell
173,025
-11,357
-6% -$68.9K ﹤0.01% 3815
2024
Q4 		$2.43M Sell
184,382
-172
-0.1% -$2.35K ﹤0.01% 2673
2024
Q3 		$2.07M Sell
184,554
-44,139
-19% -$552K ﹤0.01% 2723
2024
Q2 		$2.46M Buy
228,693
+29,629
+15% +$382K ﹤0.01% 2680
2024
Q1 		$2.97M Sell
199,064
-11,576
-5% -$191K ﹤0.01% 2564
2023
Q4 		$3.81M Buy
210,640
+10,416
+5% +$158K ﹤0.01% 2501
2023
Q3 		$3.47M Buy
200,224
+15,578
+8% +$270K ﹤0.01% 2512
2023
Q2 		$3.35M Buy
184,646
+159,258
+627% +$3.77M ﹤0.01% 2555
2023
Q1 		$675K Buy
25,388
+10,711
+73% +$305K ﹤0.01% 3329
2022
Q4 		$284K Sell
14,677
-20,437
-58% -$427K ﹤0.01% 3818
2022
Q3 		$733K Buy
35,114
+24,544
+232% +$470K ﹤0.01% 3362
2022
Q2 		$85K Sell
10,570
-62,729
-86% -$402K ﹤0.01% 4261
2022
Q1 		$513K Sell
73,299
-163
-0.2% -$1.66K ﹤0.01% 3689
2021
Q4 		$992K Sell
73,462
-1,008
-1% -$16K ﹤0.01% 3392
2021
Q3 		$1.26M Buy
74,470
+15,180
+26% +$322K ﹤0.01% 3270
2021
Q2 		$1.73M Sell
59,290
-116,658
-66% -$3.63M ﹤0.01% 3092
2021
Q1 		$6.92M Buy
175,948
+81,497
+86% +$2.65M ﹤0.01% 2287
2020
Q4 		$2.15M Buy
94,451
+8,261
+10% +$207K ﹤0.01% 2805
2020
Q3 		$1.95M Buy
86,190
+66,048
+328% +$1.65M ﹤0.01% 2684
2020
Q2 		$654K Buy
+20,142
New +$535K ﹤0.01% 3336

Other funds holding PLRX

MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BDFN
Bond & Devick Financial Network St. Louis Park, Minnesota $406M AUM 16.49% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

Bank of New York Mellon's PLRX Position: Q2 2026 in Review

Bank of New York Mellon increased its Pliant Therapeutics (PLRX) stake by 1.3% in Q2 2026, buying an estimated $253 and bringing the position to 16,032 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4268.

Bank of New York Mellon first reported a position in PLRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.92M in Q1 2021. 18 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Bank of New York Mellon held 16,032 shares of Pliant Therapeutics worth $18.3K as of Q2 2026.
  • Bank of New York Mellon bought 208 Pliant Therapeutics shares in Q2 2026, an estimated $253.
  • Pliant Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4268 holding.
  • Bank of New York Mellon first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Bank of New York Mellon's Pliant Therapeutics position peaked at $6.92M in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.